Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the second quarter ending June 30, 2013 on Thursday, August 8, 2013, after the U.S. financial markets close.
Management will provide an update on the company, discuss second quarter results, and discuss expectations for the future via conference call on Thursday, August 8, 2013 at 4:30 p.m. ET. To access the call, please dial 877-312-7507 (domestic) or 631-813-4828 (international) five minutes prior to the start time and refer to conference ID 26479248.
Help employers find you! Check out all the jobs and post your resume.
